User profiles for J. Dinunzio
James C DinunzioPrincipal Scientist Verified email at utexas.edu Cited by 2399 |
Dry powder coating of pharmaceuticals: A review
D Sauer, M Cerea, J DiNunzio, J McGinity - International journal of …, 2013 - Elsevier
Over the last half century, film coating technology has evolved significantly in terms of
compositions and manufacturing processes, allowing for greater functionality, flexibility and …
compositions and manufacturing processes, allowing for greater functionality, flexibility and …
Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole
JC DiNunzio, DA Miller, W Yang… - Molecular …, 2008 - ACS Publications
Amorphous engineered particle compositions of itraconazole (ITZ) and potential concentration
enhancing polymers, cellulose acetate phthalate (CAP) and polyvinyl acetate phthalate (…
enhancing polymers, cellulose acetate phthalate (CAP) and polyvinyl acetate phthalate (…
Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing
JC DiNunzio, C Brough, JR Hughey, DA Miller… - European journal of …, 2010 - Elsevier
Many techniques for the production of solid dispersions rely on elevated temperatures and
prolonged material residence times, which can result in decomposition of temperature-…
prolonged material residence times, which can result in decomposition of temperature-…
Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition
DA Miller, JC DiNunzio, W Yang… - Drug development …, 2008 - Taylor & Francis
Previous attempts to improve the dissolution and absorption properties of itraconazole (ITZ)
through advanced formulation design have focused only on release in acidic media; however…
through advanced formulation design have focused only on release in acidic media; however…
Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption
DA Miller, JC DiNunzio, W Yang, JW McGinity… - Pharmaceutical …, 2008 - Springer
Purpose To investigate the use of Carbopol® 974P as a stabilizing agent for supersaturated
levels of itraconazole (ITZ) in neutral pH aqueous media and the resultant effects on oral …
levels of itraconazole (ITZ) in neutral pH aqueous media and the resultant effects on oral …
[BOOK][B] Pharmaceutical extrusion technology
…, I Ghebre-Selassie, CE Martin, F Zhang, J DiNunzio… - 2003 - taylorfrancis.com
Pharmaceutical Extrusion Technology is the only resource to provide in-depth descriptions
and analyses of the key parameters of extruders and extrusion processes. The book …
and analyses of the key parameters of extruders and extrusion processes. The book …
CNS disorders—current treatment options and the prospects for advanced therapies
JC DiNunzio, RO Williams III - Drug development and industrial …, 2008 - Taylor & Francis
The development of new pharmaceutical products has successfully addressed a multitude
of disease states; however, new product development for treating disorders of the central …
of disease states; however, new product development for treating disorders of the central …
Applications of KinetiSol® Dispersing for the production of plasticizer free amorphous solid dispersions
JC DiNunzio, C Brough, DA Miller… - European journal of …, 2010 - Elsevier
Thermal manufacturing methods for the production of solid dispersions frequently require the
addition of a plasticizer in order to achieve requisite molten material flow properties when …
addition of a plasticizer in order to achieve requisite molten material flow properties when …
Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and …
JR Hughey, JC DiNunzio, RC Bennett, C Brough… - AAPs …, 2010 - Springer
In this study, hot melt extrusion (HME) and KinetiSol® Dispersing (KSD) were utilized to prepare
dissolution-enhanced solid dispersions of Roche Research Compound A (ROA), a BCS …
dissolution-enhanced solid dispersions of Roche Research Compound A (ROA), a BCS …
Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing
JC DiNunzio, JR Hughey, C Brough… - Drug development …, 2010 - Taylor & Francis
Objectives: To investigate the ability of KinetiSol® Dispersing to prepare amorphous solid
dispersions of itraconazole using concentration-enhancing polymers. Methods: Concentration-…
dispersions of itraconazole using concentration-enhancing polymers. Methods: Concentration-…